Nxt-1 inhibitors represent a diverse class of chemical compounds designed to target and disrupt the function of the Nxt-1 protein, which is involved in the cellular machinery responsible for the nuclear export of various biomolecules, including mRNA, tRNA, and proteins. The nucleus-cytoplasm transport of these molecules is a fundamental cellular process crucial for the regulation of gene expression, cellular growth, and maintenance of homeostasis. Nxt-1, also known as Exportin T, is a key player in this export process, as it recognizes and facilitates the transport of cargo molecules from the nucleus to the cytoplasm through nuclear pore complexes.
These inhibitors are engineered to interfere with the essential role played by Nxt-1 in the nucleo-cytoplasmic transport system. Common mechanisms of action for these inhibitors include binding to specific regions of Nxt-1, thus disrupting its association with cargo molecules, inhibiting its enzymatic activities, or disrupting the formation of essential protein complexes. For instance, compounds like Leptomycin B and Selinexor work by binding to CRM1, a cofactor of Nxt-1, blocking the formation of the CRM1-Nxt-1 complex that is essential for nuclear export. Others, such as Sinefungin, inhibit Nxt-1's methyltransferase activity, affecting mRNA methylation and export. The exact mechanisms and binding sites can vary among Nxt-1 inhibitors, but their overarching goal is to halt or perturb the cellular export of biomolecules, which can have profound effects on cellular functions and be exploited for various research purposes. Nxt-1 inhibitors are thus valuable tools for investigating the intricacies of nucleo-cytoplasmic transport and have provided insights into the molecular processes governing gene expression and cellular regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verdinexor | 1392136-43-4 | sc-492602 | 5 mg | $395.00 | ||
Verdinexor inhibits Nxt-1 by binding to its nuclear export signal (NES), blocking the export of cargo proteins, including tumor suppressors, leading to their accumulation in the nucleus and subsequent anti-cancer effects. | ||||||
KPT 330 | 1393477-72-9 | sc-489062 | 5 mg | $173.00 | ||
KPT 330 (Selinexor) works by binding to and inhibiting Nxt-1, preventing the nuclear export of various proteins, including tumor suppressors, leading to their nuclear retention and potential anti-cancer activities. | ||||||
Sinefungin | 58944-73-3 | sc-203263 sc-203263B sc-203263C sc-203263A | 1 mg 100 mg 1 g 10 mg | $271.00 $5202.00 $40368.00 $704.00 | 4 | |
Sinefungin acts as a competitive inhibitor of Nxt-1's methyltransferase activity, interfering with mRNA methylation and export processes. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Leptomycin B binds to CRM1, a cofactor of Nxt-1, and prevents the formation of the CRM1-Nxt-1 complex, thereby inhibiting protein nuclear export. | ||||||
Ratjadone A, Synthetic | 163564-92-9 | sc-203234 | 2 µg | $168.00 | 2 | |
Ratjadone A is a natural product that inhibits Nxt-1 by binding to it and disrupting the nuclear export of proteins. | ||||||
Tubercidin | 69-33-0 | sc-258322 sc-258322A sc-258322B | 10 mg 50 mg 250 mg | $184.00 $663.00 $1958.00 | ||
Tubercidin is an adenosine analog that interferes with Nxt-1 function, potentially by inhibiting ATP binding and disrupting export processes. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
Rotenone is a mitochondrial complex I inhibitor, which indirectly affects Nxt-1 through cellular processes that are not fully understood. | ||||||